Last reviewed · How we verify
surfactant and air (placebo) — Competitive Intelligence Brief
marketed
Respiratory
Small molecule
Live · refreshed every 30 min
Target snapshot
surfactant and air (placebo) (surfactant and air (placebo)) — China Medical University, China. This is a placebo control consisting of surfactant and air used in clinical trials to establish baseline comparisons for respiratory interventions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| surfactant and air (placebo) TARGET | surfactant and air (placebo) | China Medical University, China | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- surfactant and air (placebo) CI watch — RSS
- surfactant and air (placebo) CI watch — Atom
- surfactant and air (placebo) CI watch — JSON
- surfactant and air (placebo) alone — RSS
Cite this brief
Drug Landscape (2026). surfactant and air (placebo) — Competitive Intelligence Brief. https://druglandscape.com/ci/surfactant-and-air-placebo. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab